Mehta S D, Erbelding E J, Zenilman J M, Rompalo A M
Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Disease, Baltimore, MD, USA.
Sex Transm Infect. 2003 Apr;79(2):124-8. doi: 10.1136/sti.79.2.124.
Gonorrhoea is associated with adverse reproductive health outcomes, including pelvic inflammatory disease and increased HIV transmission. Our objective was to determine the association of demographic factors, sexual risk behaviours, and drug use with incident gonorrhoea reinfection among public STD clinic clients.
A retrospective cohort study conducted from January 1994 through October 1998, of heterosexual public STD clinic attendees age >/=12 years having at least one gonorrhoea infection in Baltimore, MD. The outcome was first incident gonorrhoea reinfection over a maximum 4.8 years, compared in STD clinic clients with or without sexual risk behaviours and drug use at initial gonorrhoea infection.
910 reinfections occurred among 8327 individuals and 21 246 person years of observation, for an overall incidence of 4.28 reinfections per 100 person years (95% CI 4.03 to 4.53). Median time to reinfection was 1.00 year (95% CI 0.91 to 1.07 years). In multivariate Cox regression, increased reinfection risk was associated with male sex, younger age, greater number of recent sex partners, and having a sex partner who is a commercial sex worker. Injection drug use and coming to the clinic as an STD contact were protective. Among risk factors that differed significantly between men and women, injection drug use was protective of reinfection in men, and "any" condom use was a risk factor for reinfection in women
Reinfection represents a significant proportion of STD clinic visits for gonorrhoea. Prevention counselling and routine screening for patients at high risk for reinfection should be considered to maximally reduce transmission and resource utilisation.
淋病与不良生殖健康后果相关,包括盆腔炎和艾滋病毒传播增加。我们的目的是确定公共性传播疾病(STD)诊所患者中人口统计学因素、性风险行为和药物使用与淋病再感染之间的关联。
1994年1月至1998年10月在马里兰州巴尔的摩进行的一项回顾性队列研究,研究对象为年龄≥12岁的异性恋公共STD诊所就诊者,他们在该诊所至少感染过一次淋病。观察期最长为4.8年,比较初次感染淋病时有无性风险行为和药物使用的STD诊所患者首次发生淋病再感染的情况。
8327名个体在21246人年的观察期内发生了910次再感染,总体发病率为每100人年4.28次再感染(95%可信区间4.03至4.53)。再感染的中位时间为1.00年(95%可信区间0.91至1.07年)。在多变量Cox回归分析中,再感染风险增加与男性、年轻、近期性伴侣数量较多以及性伴侣为商业性工作者有关。注射吸毒以及作为STD接触者前来就诊具有保护作用。在男女之间有显著差异的风险因素中,注射吸毒对男性再感染有保护作用,而“任何”形式的避孕套使用对女性再感染是一个风险因素。
再感染占STD诊所淋病就诊病例的很大比例。应考虑对再感染高危患者进行预防咨询和常规筛查,以最大程度减少传播和资源利用。